Gene · 996
Papers1,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study. | Immunohorizons | 2023 | 36637516 | PubTator, text mining | PubMed |
| Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report. | BMC Med Genomics | 2023 | 36604730 | PubTator, text mining | PubMed |
| Proteomics reveals that cell density could affect the efficacy of drug treatment. | Biochem Biophys Rep | 2023 | 36561432 | PubTator, text mining | PubMed |
| Nuclear-localized CTEN is a novel transcriptional regulator and promotes cancer cell migration through its downstream target CDC27. | J Physiol Biochem | 2023 | 36399312 | PubTator, text mining | PubMed |
| Alternative pathway activation in pregnancy, a measured amount "complements" a successful pregnancy, too much results in adverse events. | Immunol Rev | 2023 | 36377667 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond. | Immunol Rev | 2023 | 36097870 | PubTator, text mining | PubMed |
| Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases. | Immunol Rev | 2023 | 36089777 | PubTator, text mining | PubMed |
| Tracking of Stem Cells from Human Exfoliated Deciduous Teeth Labeled with Molday ION Rhodamine-B during Periodontal Bone Regeneration in Rats. | Int J Stem Cells | 2023 | 36042010 | PubTator, text mining | PubMed |
| The production and secretion of tRNA-derived RNA fragments in the corn smut fungus Ustilago maydis. | Front Fungal Biol | 2022 | 37746175 | PubTator, text mining | PubMed |
| Multiregional Sequencing Analysis Reveals Extensive Genetic Heterogeneity in Gastric Tumors from Latinos. | Cancer Res Commun | 2022 | 36970058 | PubTator, text mining | PubMed |
| Racial disparities in the genetic landscape of lung cancer. | Cancer Health Disparities | 2022 | 36819657 | PubTator, text mining | PubMed |
| Fourth Report on Chicken Genes and Chromosomes 2022. | Cytogenet Genome Res | 2022 | 36716736 | PubTator, text mining | PubMed |
| Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss. | Biomedicines | 2022 | 36672540 | PubTator, text mining | PubMed |
| A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration. | Front Immunol | 2022 | 36643920 | PubTator, text mining | PubMed |
| The Role of miRNAs in the Prognosis of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. | Diagnostics (Basel) | 2022 | 36611419 | PubTator, text mining | PubMed |
| APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer's disease. | Front Pharmacol | 2022 | 36588673 | PubTator, text mining | PubMed |
| Expression, tumor immune infiltration, and prognostic impact of HMGs in gastric cancer. | Front Oncol | 2022 | 36568211 | PubTator, text mining | PubMed |
| Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 36555712 | PubTator, text mining | PubMed |
| Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models. | Biomedicines | 2022 | 36551904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/996/papers?page=8